FAQ

Actinium Ac 225 Lintuzumab

Known as: 225Ac-HuM195, Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195 
A radioimmunoconjugate consisting of the humanized monoclonal antibody lintuzumab conjugated to the alpha-emitting radioisotope actinium Ac 225 with… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2015
0119952015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Novel drugs for older patients with acute myeloid leukemia
Acute myeloid leukemia (AML) is the second most common form of leukemia and the most frequent cause of leukemia-related deaths in… (More)
  • figure 1
  • table 1
Is this relevant?
2004
2004
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
UNLABELLED Short-lived alpha-emitting isotopes individually conjugated to monoclonal antibodies have now reached human use, but… (More)
Is this relevant?
1995
1995
Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia.
Humanized M195 (HuM195) is a genetically engineered, human IgG1 version of the parent M195, a mouse immunoglobulin G2a, anti-CD33… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?